Abstract:Myocardial infarction (MI) remains a leading cause of mortality worldwide. Despite patients with MI benefit from timely reperfusion therapies, the rates of mortality and morbidity remain substantial, suggesting an enduring need for the development of new approaches. Molecular mechanisms underlying myocardial ischemic injury are associated with both cardiomyocytes and non-cardiomyocytes. Exosomes are nano-sized extracellular vesicles released by almost all eukaryotic cells. They facilitate the communication between various cells by transferring information via their cargo and altering different biological activities in recipient cells. Studies have created great prospects for therapeutic applications of exosomes in MI, as demonstrated through their beneficial effect on heart function and reducing ventricular remodeling in association with fibrosis, angiogenesis, apoptosis, and inflammation. Of note, myocardial ischemic injury is primarily due to restricted blood flow, reducing oxygen availability, and causing inefficient utilization of energy substrates. However, the impact of exosomes on cardiac energy metabolism has not been adequately investigated. Although exosomes have been engineered for targeted delivery to enhance clinical efficacy, challenges must be overcome to utilize them reliably in the clinic. In this review, we summarize the research progress of exosomes for MI with a focus on the known and unknown regarding the role of exosomes in energy metabolism in cardiomyocytes and non-cardiomyocytes; as well as potential research avenues of exosome-mitochondrial energy regulation as well as therapeutic challenges. We aim to help identify more efficient molecular targets that may promote the clinical application of exosomes.

Engineering Exosomes to Specifically Target the Mitochondria of Brain Cells

Engineered Exosomes: A Promising Drug Delivery Strategy for Brain Diseases

Engineered exosomes: desirable target-tracking characteristics for cerebrovascular and neurodegenerative disease therapies

Engineered exosomes derived from stem cells: a new brain-targeted strategy

A promising therapeutic: Exosome-mediated mitochondrial transplantation

Exosomes: A Cellular Communication Medium That Has Multiple Effects On Brain Diseases

Exosomes and Their Derivatives As Biomarkers and Therapeutic Delivery Agents for Cardiovascular Diseases: Situations and Challenges.

Brain-targeted heptapeptide-loaded exosomes attenuated ischemia–reperfusion injury by promoting the transfer of healthy mitochondria from astrocytes to neurons

Extracellular vesicles: opening up a new perspective for the diagnosis and treatment of mitochondrial dysfunction

Targeted drug delivery of engineered mesenchymal stem/stromal-cell-derived exosomes in cardiovascular disease: recent trends and future perspectives

Harnessing Exosomes for the Development of Brain Drug Delivery Systems

Engineering exosomes for targeted drug delivery

Omnidirectional improvement of mitochondrial health in Alzheimer's disease by multi-targeting engineered activated neutrophil exosomes

Exosomes for neurodegenerative diseases: diagnosis and targeted therapy

Plant-derived Exosomes As Cell Homogeneous Nanoplatforms for Brain Biomacromolecules Delivery Ameliorate Mitochondrial Dysfunction Against Parkinson’s Disease

Neural stem cell-derived exosomes promote mitochondrial biogenesis and restore abnormal protein distribution in a mouse model of Alzheimer's disease

Diagnostic and Therapeutic Potential of Exosomes in Neurodegenerative Diseases

From exosomes to mitochondria and myocardial infarction: Molecular insight and therapeutic challenge

[Mitochondrial therapy: a new strategy for treating mitochondrion-associated diseases]

Engineered exosomes enriched with select microRNAs amplify their therapeutic efficacy for traumatic brain injury and stroke

Exosomes as a therapeutic tool to promote neurorestoration and cognitive function in neurological conditions: Achieve two ends with a single effort